alexa Foreword to Special Issue on Neuropharmacology and Neurotoxicity | OMICS International
ISSN: 2161-0495
Journal of Clinical Toxicology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Foreword to Special Issue on Neuropharmacology and Neurotoxicity

Michael Aschner*

Department of Molecular Pharmacology, Albert Einstein College of Medicine, USA

*Corresponding Author:
Michael Aschner
Department of Molecular Pharmacology
Albert Einstein College of Medicine
Forchheimer 209, 1300 Morris Park Avenue
Bronx, USA
Tel: 718.430.2317
E-mail: [email protected]

Received date: September 10, 2013; Accepted date: September 11, 2013; Published date: September 15, 2013

Citation: Aschner M (2013) Foreword to Special Issue on Neuropharmacology and Neurotoxicity. J Clinic Toxicol S6:e001. doi: 10.4172/2161-0495.S6-e001

Copyright: © 2013 Aschner M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical Toxicology

Harm inflicted upon the nervous system from thousands of synthetic substances and natural productsis well documented, yet far from being understood. As such, assessment and characterization of issues extending to neuropharmacology and neurotoxicity is deemed timely. The current issue is multidisciplinary in nature, addressing a plethora of topics, ranging from basic biology to biotechnology.

The last decade has ushered rapid advances in modeling, toxicogenomics, bioinformatics, epigenetics, imagingas well as computational pharmacology and toxicology, to name a few. Great emphasis has also been placed on addressing the utility of in vitro methods and complimentary in vivo animal models to advance the understanding of neuropharmacology and neurotoxicity, while concomitantly reducing the need for mammals in experimentation. Emphasis has also been placed on genetics/transgenic models with inherent high throughput capacity to accelerate theidentification of candidate genes that modulate toxic outcomes and pharmacokinetics. Altogether, the issue provides state-of-the-art account on emerging methods and mechanisms by which pharmacological and environmental compounds mitigate or trigger neurological disorders, respectively.

Several articles address neuropharmacologic and toxicological mechanisms associated with neurodegenerative diseases. Better understanding of the pathophysiology of such disorders and the search for efficacious neuroprotective measures and therapeutics to combat the increasing prevalence of Parkinson’s disease and Alzheimer’s disease (and others) highlight pertinent issues facing public health fora and industry around the globe. Violence and crime, and their potential relationship to heavy metals are also addressed, underpinning neurotransmitter disturbances that may trigger such behaviors. Human studies also highlight the characteristics potential remedies for the visual disturbances associated with alcoholic ketoacidosis. Efficacious therapy is also discussed within the context of multidrug resistanceand Acquired Immunodeficiency Syndrome (AIDS).

Other articles highlight advances in brain imaging and its application to cognitive experimental and brain sciences, addressing connectivity between the memory and craving systems in brains of chronic cocaine users. The utility of tissue culture methodology in deciphering basic molecular toxicity (demyelination) is also demonstrated, modeling inflammatory responses in aggregating brain cell cultures. The Tissue Repair and Angiogenesis (TRAG) network highlights advances in computational toxicology as means of quantifying the biological impact of exposure to environmental toxicants via the use of computable network models and network scoring methods. Several case reports highlight the toxicity of natural compounds (e.g. ibogaine), suggesting the need for additional studies on their mechanisms of toxicity and raising questions about their usage in clinical settings. Other studies, demonstrate the utility of naturally derived compounds (e.g. Spinosad) as means for controlling mosquito larviciding.

In assembling a cadre of excellent articles the editors highlight the rigor and excellence inherent to the Journal of Clinical Toxicology. The carefully selected topics exude high quality and bring needed attention to a compendium of timely and wide range of neuropharmacology and toxicology topics. Cellular and molecular biology themes are well illustrated, and cell-specific toxic effects are mechanistically exemplified. Overall, this volume provides an excellent reference with in-depth analysis and provocative discussions, and it should speak to neuropharmacologists and toxicologists in all employment domains (government, industry, academia and consulting).

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11821
  • [From(publication date):
    specialissue-2013 - Jul 16, 2018]
  • Breakdown by view type
  • HTML page views : 8060
  • PDF downloads : 3761

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7